Health Affairs, 23, no. 1 (2004): 64-76 doi: 10.1377/hlthaff.23.1.64 © 2004 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Campbell, E. G. Articles by Biles, B. Search for Related Content PubMed PubMed Citation Articles by Campbell, E. G. Articles by Biles, B. Related Collections Pharmaceuticals Research And Technology

Environment

Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences

The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities. Future efforts with regard to technology transfer in the life sciences will need to recognize its importance without ignoring concerns or overestimating benefits. Next steps include better monitoring of university–industry relationships, the development of a better data system, the dissemination of best practices in technology transfer management, and evaluation of national technology-transfer policies.

                      What's this?

This article has been cited by other articles:

				S. D. Brown, J. C. Daly, L. A. Kalish, and S. A. McDaniel Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association with Reporting of Non-Food and Drug Administration-approved Uses of Industry Products Radiology, June 1, 2006; 239(3): 849 - 855. [Abstract] [Full Text] [PDF]

				G. K. Sobolski, J. H. Barton, and E. J. Emanuel Technology Licensing: Lessons From the US Experience JAMA, December 28, 2005; 294(24): 3137 - 3140. [Full Text] [PDF]

				G. K. Sobolski Biotechnology Products and University-Based Science JAMA, June 15, 2005; 293(23): 2862 - 2862. [Full Text] [PDF]